TECH Wire Story Reactions & EOD Technical StudyDaily closes (Databento EOD) pinned with every AlgoThesis Wire story (dot colour = next trading day close) and SEC filing
Nov 5, 2026CLOSE $72.661D −0.10%3M +0.75%SMA20 $72.60SMA50 $72.48RSI(14) 55.7
Data provided by Databento (end of day). Next close = the first close after a story against the close before it; official daily closes only, not a call, not advice.
The numbers
fiscal 2026, as filed with the SEC · 66-metric EOD snapshot via Databento
Market cap$11.4B
EV / True FCF50.2x
Revenue$1.2B −0.4%
True FCF (ex-SBC)$221.9M +2.6%
Rule of 4021.3%
ROIC10.3%
True FCF Yield1.9%
EPS, diluted$1.16 +152.2%
Modern Valuation (EOD)
Market Cap$11.4B
Enterprise Value$11.1B
EV / True FCF50.19
EV / FCF42.30
EV / Gross Profit13.93
EV / EBIT44.21
EV / Sales9.16
P / E (GAAP)62.61
P / FCF43.26
P / Oper. CF38.99
P / Book5.40
Owner & Cash Yields
True FCF Yield1.9%
FCF Yield2.3%
Owner Earn. Yield1.8%
Earnings Yield1.6%
Shareholder Yield+0.4%
Buyback Yield0.4%
Dividend Yield0.44%
Dividend / sh$0.32
Payout Ratio27%
FCF / sh$1.68
EPS (diluted)$1.16
Compounder & Returns
Rule of 4021.3%
ROIC10.3%
Cash ROIC (CROIC)14.2%
GP / Assets30.9%
ROE8.6%
ROA7.0%
Gross Margin65.8%
Oper. Margin20.7%
Net Margin15.0%
FCF Margin21.7%
True FCF Margin18.3%
Quality & Dilution
Cash Conversion145%
Accrual Ratio−4.3%
SBC % of FCF15.7%
SBC % of Rev3.4%
Reinvest. Rate10%
Sales Growth Y/Y−0.4%
Sales 3Y CAGR+2.2%
EPS Growth Y/Y+152.2%
FCF Growth Y/Y+2.6%
FCF 3Y CAGR+6.8%
Share Change Y/Y−1.7%
Balance Sheet & Scale
Revenue (FY)$1.2B
Gross Profit (FY)$799.1M
Oper. Income (FY)$251.9M
GAAP Net Income$181.9M
True FCF (ex-SBC)$221.9M
Cash & Equiv$264.7M
Total Debt$12.5M
Net Cash (Debt)$252.2M
Net Cash % MCap+2.2%
Debt / FCF (yrs)0.1y
Current Ratio4.55157.06M sh
Price & Technicals (EOD)
Perf Week−0.07%
Perf Month+0.18%
Perf Quarter+0.51%
Perf Half Y+42.72%
Perf YTD+19.94%
SMA 20 Dist+0.08%$72.60
SMA 50 Dist+0.25%$72.48
SMA 100 Dist+2.05%$71.20
Window High−0.10%$72.73
Window Low+67.81%$43.30
RSI (14) · Vol55.72%v
Income Distribution & Cash Flow ConversionHow every dollar of TECH revenue flows through cost of goods, operating expenses, taxes, GAAP net income, and dilution-adjusted free cash flow
Standard Free Cash Flow (FCF)$263.2M(21.7% margin)
Less: Stock-Based Comp (SBC)−$41.4M(15.7% of FCF)
True FCF (Owner Cash ex-SBC)$221.9M(18.3% of rev)
Revenue by fiscal year
$1.1BFY22
$1.1BFY23
$1.2BFY24
$1.2BFY25
$1.2BFY26
Operating leverage — margins
GrossOperatingNet
Unlocked SEC EDGAR Accounting Statements (USD)All 3 statements · Common-size (% of Revenue / Assets) · YoY growth · Tap any core row to explain
Line Item (USD)
FY2022
FY2023
FY2024
FY2025
FY2026
YoY Δ
4Y CAGR
Trend
Income Statement
Revenue ▸
$1.1B
$1.1B
$1.2B
$1.2B
$1.2B
−0.4%
+2.4%
Cost of Revenue (COGS)
$349.1M
$366.9M
$389.3M
$429.4M
$416.0M
−3.1%
+4.5%
Gross Profit ▸
$756.5M
$769.8M
$769.7M
$790.3M
$799.1M
+1.1%
+1.4%
Selling, General & Admin (SG&A)
$372.8M
$378.4M
$466.4M
$588.5M
$452.4M
−23.1%
+5.0%
Total Operating Expenses
$459.9M
$470.9M
$563.0M
$688.0M
$547.2M
−20.5%
+4.4%
Operating Income (EBIT) ▸
$296.6M
$298.9M
$206.7M
$102.3M
$251.9M
+146.3%
−4.0%
Interest Expense
$11.3M
$11.2M
$15.7M
$8.5M
$9.6M
+13.2%
−3.9%
Income Tax Expense
$38.3M
$53.2M
$17.6M
$25.1M
$58.8M
+134.7%
+11.3%
GAAP Net Income ▸
$272.1M
$285.3M
$168.1M
$73.4M
$181.9M
+147.8%
−9.6%
Diluted EPS ▸
$1.66
$1.76
$1.05
$0.46
$1.16
+152.2%
−8.6%
Diluted Shares
164.1M
161.9M
160.8M
159.7M
157.0M
−1.7%
−1.1%
Balance Sheet
Cash & Equivalents
$172.6M
$180.6M
$151.8M
$162.2M
$264.7M
+63.2%
+11.3%
Inventory
$141.1M
$171.6M
$179.7M
$189.4M
$195.7M
+3.3%
+8.5%
Total Current Assets
$605.6M
$621.5M
$617.4M
$608.3M
$744.4M
+22.4%
+5.3%
Total Assets
$2.3B
$2.6B
$2.7B
$2.6B
$2.6B
+1.1%
+3.0%
Total Current Liabilities
$176.0M
$128.5M
$159.4M
$175.8M
$163.7M
−6.9%
−1.8%
Total Debt (Short + Long Term)
$12.5M
$12.5M
$12.5M
$12.5M
$12.5M
+0.0%
+0.0%
Stockholders' Equity
$1.7B
$2.0B
$2.1B
$1.9B
$2.1B
+9.9%
+5.5%
Net Cash / (Net Debt)
$160.1M
$168.1M
$139.3M
$149.7M
$252.2M
+68.5%
+12.0%
Invested Capital
$1.5B
$1.8B
$1.9B
$1.8B
$1.9B
+4.9%
+4.8%
Cash Flow & Capital Allocation
Operating Cash Flow (OCF) ▸
$325.3M
$254.4M
$299.0M
$287.6M
$292.1M
+1.6%
−2.7%
Depreciation & Amortization (D&A)
$101.1M
$107.2M
$111.7M
$109.9M
$97.4M
−11.4%
−0.9%
Stock-Based Compensation (SBC)
$42.2M
$39.2M
$38.0M
$40.8M
$41.4M
+1.3%
−0.5%
Capital Expenditures (CapEx)
$44.9M
$38.2M
$62.9M
$31.0M
$28.9M
−7.0%
−10.5%
Free Cash Flow (FCF) ▸
$280.4M
$216.1M
$236.1M
$256.6M
$263.2M
+2.6%
−1.6%
True FCF (ex-SBC Owner Cash)
$238.2M
$176.9M
$198.1M
$215.7M
$221.9M
+2.8%
−1.8%
Share Repurchases (Buybacks)
$160.9M
$19.6M
$80.0M
$275.7M
$41.7M
−84.9%
−28.7%
Dividends Paid
$50.2M
$50.3M
$50.4M
$50.4M
$49.9M
−0.9%
−0.1%
Fundamentals, income distribution and multi-year statements from SEC EDGAR filings (public domain). Valuation multiples, performance and technicals computed from Databento 1D EOD closes. For information only, not investment advice.
On the Wire
what TECH did at the next close after each story
No Wire story has named TECH yet.
The Wire at 7 AM ET, free. Top stories with a bull and a bear case on each, every morning. No account needed.
What happened · big days
72 big days in a year, and what we hold on each
A big day is a close more than 1.96% from the one before, three times TECH’s median day (0.65%). On 19 of the 72, its peer group moved the same way at least half as far. We show what we hold. We never name a cause.
every other trading daya big day, numbered in the list below±1.96%Hover a bar for its day. Click a big day to open it.
Shaded: since our stories began, Jun 10. Tap a bar for its day.
#DayTECHWhat we hold that dayGroup (median of 4) · each
1 Nov 6, 2025−2.94%
Before our storiesgroup +1.4%, did not move with it
1Nov 6, 2025−2.94%
Before our stories
+1.4% did not move with itAMGN −1.3 · GILD +0.7 · BIIB +2.2 · MRNA +3.3
2 Nov 11, 2025+2.99%
Before our storiesgroup +4.2%, moved with TECH
2Nov 11, 2025+2.99%
Before our stories
+4.2% moved with TECHMRNA +6.7 · AMGN +4.6 · GILD +3.7 · BIIB +2.1
3 Nov 12, 2025+3.75%
Before our storiesgroup +0.9%, did not move with it
3Nov 12, 2025+3.75%
Before our stories
+0.9% did not move with itBIIB +1.2 · MRNA +1.1 · GILD +0.7 · AMGN −0.6
4 Nov 14, 2025−2.26%
Before our storiesgroup +0.0%, did not move with it
4Nov 14, 2025−2.26%
Before our stories
+0.0% did not move with itMRNA −0.8 · GILD −0.1 · AMGN +0.2 · BIIB +1.7
5 Nov 21, 2025+4.77%
Before our storiesgroup +2.8%, moved with TECH
5Nov 21, 2025+4.77%
Before our stories
+2.8% moved with TECHMRNA +6.1 · BIIB +4.2 · GILD +1.3 · AMGN +0.4
6 Nov 24, 2025+3.19%
Before our storiesgroup −0.0%, did not move with it
6Nov 24, 2025+3.19%
Before our stories
−0.0% did not move with itMRNA +1.8 · BIIB +0.9 · AMGN −1.0 · GILD −1.1
7 Nov 25, 2025+3.72%
Before our storiesgroup +2.3%, moved with TECH
7Nov 25, 2025+3.72%
Before our stories
+2.3% moved with TECHBIIB +2.9 · MRNA +2.5 · AMGN +2.0 · GILD +1.5
8 Dec 5, 2025−2.93%
Before our storiesgroup −0.8%, did not move with it
8Dec 5, 2025−2.93%
Before our stories
−0.8% did not move with itAMGN −3.0 · GILD −1.1 · BIIB −0.4 · MRNA +8.7
9 Dec 8, 2025−2.25%
Before our storiesgroup −0.2%, did not move with it
9Dec 8, 2025−2.25%
Before our stories
−0.2% did not move with itAMGN −2.6 · BIIB −0.5 · GILD −0.0 · MRNA +1.0
10 Dec 9, 2025−2.44%
Before our storiesgroup −1.9%, moved with TECH
10Dec 9, 2025−2.44%
Before our stories
−1.9% moved with TECHBIIB −2.5 · AMGN −2.3 · GILD −1.5 · MRNA +1.0
11 Dec 10, 2025+3.42%
Before our storiesgroup +1.3%, did not move with it
11Dec 10, 2025+3.42%
Before our stories
+1.3% did not move with itMRNA +2.8 · GILD +1.7 · BIIB +1.0 · AMGN +0.5
12 Dec 12, 2025−2.90%
Before our storiesgroup −0.2%, did not move with it
12Dec 12, 2025−2.90%
Before our stories
−0.2% did not move with itGILD −2.3 · MRNA −0.6 · AMGN +0.1 · BIIB +0.9
13 Dec 16, 2025−2.13%
Before our storiesgroup −0.5%, did not move with it
13Dec 16, 2025−2.13%
Before our stories
−0.5% did not move with itBIIB −2.4 · GILD −0.8 · MRNA −0.1 · AMGN +0.4
14 Dec 19, 2025+2.05%
Before our storiesgroup +2.6%, moved with TECH
14Dec 19, 2025+2.05%
Before our stories
+2.6% moved with TECHMRNA +9.2 · BIIB +2.9 · GILD +2.3 · AMGN +0.9
15 Jan 5, 2026+5.67%
Before our storiesgroup −1.9%, did not move with it
15Jan 5, 2026+5.67%
Before our stories
−1.9% did not move with itMRNA +4.2 · BIIB −1.8 · AMGN −2.1 · GILD −2.7
16 Jan 6, 2026+3.57%
Before our storiesgroup +3.8%, moved with TECH
16Jan 6, 2026+3.57%
Before our stories
+3.8% moved with TECHMRNA +10.8 · BIIB +4.6 · AMGN +3.0 · GILD +2.6
17 Jan 14, 2026+3.07%
Before our storiesgroup +1.7%, moved with TECH
17Jan 14, 2026+3.07%
Before our stories
+1.7% moved with TECHMRNA +2.5 · GILD +1.9 · AMGN +1.4 · BIIB −5.0
18 Jan 15, 2026+2.28%
Before our storiesgroup −1.4%, did not move with it
18Jan 15, 2026+2.28%
Before our stories
−1.4% did not move with itAMGN +0.3 · BIIB −0.4 · GILD −2.3 · MRNA −3.0
19 Jan 21, 2026+2.60%
Before our storiesgroup +4.2%, moved with TECH
19Jan 21, 2026+2.60%
Before our stories
+4.2% moved with TECHMRNA +15.8 · BIIB +4.4 · GILD +4.0 · AMGN +3.8
20 Jan 22, 2026−2.42%
Before our storiesgroup +1.3%, did not move with it
20Jan 22, 2026−2.42%
Before our stories
+1.3% did not move with itBIIB +0.7 · AMGN +1.0 · GILD +1.6 · MRNA +4.1
21 Jan 23, 2026−2.14%
Before our storiesgroup −1.0%, did not move with it
21Jan 23, 2026−2.14%
Before our stories
−1.0% did not move with itMRNA −6.1 · BIIB −1.3 · AMGN −0.7 · GILD +3.6
22 Jan 28, 2026−3.91%
Before our storiesgroup −0.6%, did not move with it
22Jan 28, 2026−3.91%
Before our stories
−0.6% did not move with itAMGN −2.6 · GILD −0.9 · MRNA −0.3 · BIIB +0.4
23 Jan 29, 2026−2.41%
Before our storiesgroup +0.5%, did not move with it
23Jan 29, 2026−2.41%
Before our stories
+0.5% did not move with itGILD −0.1 · AMGN +0.2 · BIIB +0.8 · MRNA +3.4
24 Feb 4, 2026+6.25%
Resultsgroup +3.5%, moved with TECH
24Feb 4, 2026+6.25%
ResultsFirst close after the Feb 4 results filing
+3.5% moved with TECHAMGN +8.2 · BIIB +4.9 · GILD +2.1 · MRNA +1.4
25 Feb 5, 2026−4.09%
Before our storiesgroup +0.2%, did not move with it
25Feb 5, 2026−4.09%
Before our stories
+0.2% did not move with itMRNA −4.4 · BIIB −0.1 · AMGN +0.4 · GILD +2.1
26 Feb 11, 2026−2.08%
Before our storiesgroup +0.8%, did not move with it
26Feb 11, 2026−2.08%
Before our stories
+0.8% did not move with itMRNA −3.5 · AMGN +0.5 · BIIB +1.2 · GILD +5.8
27 Feb 12, 2026−6.16%
Before our storiesgroup −0.6%, did not move with it
27Feb 12, 2026−6.16%
Before our stories
−0.6% did not move with itGILD −2.6 · MRNA −1.0 · AMGN −0.1 · BIIB +2.3
28 Feb 17, 2026−2.39%
Before our storiesgroup +0.7%, did not move with it
28Feb 17, 2026−2.39%
Before our stories
+0.7% did not move with itBIIB −0.5 · GILD +0.2 · AMGN +1.1 · MRNA +4.0
29 Feb 23, 2026−4.80%
Before our storiesgroup +1.0%, did not move with it
29Feb 23, 2026−4.80%
Before our stories
+1.0% did not move with itGILD −1.0 · MRNA +0.8 · AMGN +1.3 · BIIB +2.2
30 Feb 24, 2026+5.19%
Before our storiesgroup −0.1%, did not move with it
30Feb 24, 2026+5.19%
Before our stories
−0.1% did not move with itAMGN +0.9 · MRNA +0.5 · BIIB −0.6 · GILD −1.5
31 Mar 2, 2026−2.00%
Before our storiesgroup −1.0%, did not move with it
31Mar 2, 2026−2.00%
Before our stories
−1.0% did not move with itBIIB −2.0 · MRNA −1.4 · AMGN −0.6 · GILD +0.7
32 Mar 5, 2026−3.39%
Before our storiesgroup −2.6%, moved with TECH
32Mar 5, 2026−3.39%
Before our stories
−2.6% moved with TECHMRNA −6.9 · AMGN −3.1 · GILD −2.1 · BIIB −1.0
33 Mar 6, 2026−3.58%
Before our storiesgroup −1.3%, did not move with it
33Mar 6, 2026−3.58%
Before our stories
−1.3% did not move with itMRNA −2.4 · BIIB −1.7 · GILD −0.8 · AMGN +0.5
34 Mar 10, 2026−3.74%
Before our storiesgroup −0.2%, did not move with it
34Mar 10, 2026−3.74%
Before our stories
−0.2% did not move with itMRNA −1.4 · AMGN −0.4 · BIIB +0.1 · GILD +1.3
35 Mar 12, 2026−4.01%
Before our storiesgroup −2.8%, moved with TECH
35Mar 12, 2026−4.01%
Before our stories
−2.8% moved with TECHMRNA −4.6 · BIIB −2.9 · AMGN −2.6 · GILD −0.5
36 Mar 16, 2026−4.01%
Before our storiesgroup +0.5%, did not move with it
36Mar 16, 2026−4.01%
Before our stories
+0.5% did not move with itAMGN +0.0 · GILD +0.1 · BIIB +0.9 · MRNA +1.4
37 Mar 17, 2026+4.61%
Before our storiesgroup +0.3%, did not move with it
37Mar 17, 2026+4.61%
Before our stories
+0.3% did not move with itMRNA +1.2 · BIIB +1.1 · GILD −0.6 · AMGN −1.4
38 Mar 27, 2026−3.32%
Before our storiesgroup −2.9%, moved with TECH
38Mar 27, 2026−3.32%
Before our stories
−2.9% moved with TECHMRNA −7.5 · BIIB −3.8 · GILD −1.9 · AMGN −1.2
39 Mar 30, 2026+2.14%
Before our storiesgroup +0.8%, did not move with it
39Mar 30, 2026+2.14%
Before our stories
+0.8% did not move with itBIIB +2.0 · GILD +1.6 · AMGN +0.1 · MRNA −2.7
40 Apr 1, 2026+2.33%
Before our storiesgroup +0.3%, did not move with it
40Apr 1, 2026+2.33%
Before our stories
+0.3% did not move with itGILD +0.7 · AMGN +0.4 · BIIB +0.3 · MRNA −1.5
41 Apr 8, 2026+2.56%
Before our storiesgroup +2.7%, moved with TECH
41Apr 8, 2026+2.56%
Before our stories
+2.7% moved with TECHMRNA +4.0 · AMGN +2.9 · BIIB +2.4 · GILD +2.0
42 Apr 13, 2026+3.58%
Before our storiesgroup −0.2%, did not move with it
42Apr 13, 2026+3.58%
Before our stories
−0.2% did not move with itBIIB +2.0 · GILD +0.0 · AMGN −0.3 · MRNA −0.6
43 Apr 14, 2026+1.96%
Before our storiesgroup +1.3%, moved with TECH
43Apr 14, 2026+1.96%
Before our stories
+1.3% moved with TECHMRNA +4.3 · BIIB +1.5 · GILD +1.0 · AMGN +0.3
44 Apr 17, 2026+3.26%
Before our storiesgroup +0.1%, did not move with it
44Apr 17, 2026+3.26%
Before our stories
+0.1% did not move with itAMGN +1.7 · BIIB +0.8 · GILD −0.7 · MRNA −1.8
45 Apr 20, 2026+2.28%
Before our storiesgroup +0.2%, did not move with it
45Apr 20, 2026+2.28%
Before our stories
+0.2% did not move with itBIIB +3.4 · MRNA +1.6 · GILD −1.3 · AMGN −1.4
46 Apr 23, 2026−10.89%
Before our storiesgroup −0.3%, did not move with it
46Apr 23, 2026−10.89%
Before our stories
−0.3% did not move with itMRNA −5.0 · BIIB −1.1 · GILD +0.6 · AMGN +0.8
47 Apr 24, 2026+3.80%
Before our storiesgroup −2.1%, did not move with it
47Apr 24, 2026+3.80%
Before our stories
−2.1% did not move with itAMGN −1.2 · BIIB −1.9 · GILD −2.4 · MRNA −4.0
48 Apr 28, 2026−2.90%
Before our storiesgroup +0.5%, did not move with it
48Apr 28, 2026−2.90%
Before our stories
+0.5% did not move with itMRNA −3.2 · AMGN −0.2 · GILD +1.2 · BIIB +1.5
49 Apr 29, 2026−2.92%
Before our storiesgroup −0.4%, did not move with it
49Apr 29, 2026−2.92%
Before our stories
−0.4% did not move with itMRNA −3.0 · AMGN −0.5 · GILD −0.3 · BIIB +6.0
50 Apr 30, 2026+6.49%
Before our storiesgroup +1.0%, did not move with it
50Apr 30, 2026+6.49%
Before our stories
+1.0% did not move with itAMGN +2.4 · GILD +1.6 · MRNA +0.5 · BIIB −2.6
51 May 5, 2026+3.54%
Before our storiesgroup +0.8%, did not move with it
51May 5, 2026+3.54%
Before our stories
+0.8% did not move with itAMGN +1.8 · BIIB +1.0 · GILD +0.6 · MRNA −1.3
52 May 6, 2026−16.36%
Resultsgroup +1.5%, did not move with it
52May 6, 2026−16.36%
ResultsFirst close after the May 6 results filing
+1.5% did not move with itAMGN +0.5 · BIIB +0.8 · GILD +2.1 · MRNA +4.5
53 May 7, 2026+7.39%
Before our storiesgroup −0.6%, did not move with it
53May 7, 2026+7.39%
Before our stories
−0.6% did not move with itBIIB +0.4 · MRNA −0.5 · AMGN −0.6 · GILD −1.6
54 May 8, 2026−5.01%
Before our storiesgroup +0.9%, did not move with it
54May 8, 2026−5.01%
Before our stories
+0.9% did not move with itGILD −2.0 · AMGN +0.8 · BIIB +1.1 · MRNA +12.0
55 May 13, 2026−5.34%
Before our storiesgroup −0.7%, did not move with it
55May 13, 2026−5.34%
Before our stories
−0.7% did not move with itMRNA −5.3 · GILD −1.4 · AMGN +0.1 · BIIB +2.6
56 May 15, 2026−3.22%
Before our storiesgroup −1.9%, moved with TECH
56May 15, 2026−3.22%
Before our stories
−1.9% moved with TECHAMGN −3.0 · MRNA −2.0 · GILD −1.9 · BIIB +0.8
57 May 18, 2026+2.61%
Before our storiesgroup −0.6%, did not move with it
57May 18, 2026+2.61%
Before our stories
−0.6% did not move with itGILD +0.1 · BIIB −0.5 · AMGN −0.6 · MRNA −1.9
58 May 19, 2026+2.34%
Before our storiesgroup −0.0%, did not move with it
58May 19, 2026+2.34%
Before our stories
−0.0% did not move with itAMGN +2.0 · GILD +0.6 · BIIB −0.7 · MRNA −5.0
59 May 20, 2026+2.71%
Before our storiesgroup +0.2%, did not move with it
59May 20, 2026+2.71%
Before our stories
+0.2% did not move with itMRNA +5.3 · AMGN +0.3 · GILD +0.1 · BIIB −1.4
60 May 28, 2026+5.72%
Before our storiesgroup +0.0%, did not move with it
60May 28, 2026+5.72%
Before our stories
+0.0% did not move with itGILD +1.9 · AMGN +0.1 · MRNA −0.1 · BIIB −0.3
61 Jun 2, 2026−2.01%
Before our storiesgroup −1.3%, moved with TECH
61Jun 2, 2026−2.01%
Before our stories
−1.3% moved with TECHGILD −2.7 · BIIB −1.8 · MRNA −0.9 · AMGN −0.3
62 Jun 3, 2026+2.17%
Before our storiesgroup +3.4%, moved with TECH
62Jun 3, 2026+2.17%
Before our stories
+3.4% moved with TECHMRNA +7.5 · BIIB +3.8 · AMGN +3.0 · GILD +1.1
63 Jun 4, 2026+4.58%
Before our storiesgroup +1.2%, did not move with it
63Jun 4, 2026+4.58%
Before our stories
+1.2% did not move with itMRNA +5.2 · AMGN +2.2 · BIIB +0.3 · GILD +0.1
64 Jun 5, 2026−2.24%
Before our storiesgroup −0.3%, did not move with it
64Jun 5, 2026−2.24%
Before our stories
−0.3% did not move with itMRNA −8.0 · BIIB −0.6 · GILD −0.0 · AMGN +1.1
65 Jun 9, 2026+3.34%
Before our storiesgroup −0.0%, did not move with it
65Jun 9, 2026+3.34%
Before our stories
−0.0% did not move with itBIIB +3.4 · MRNA +0.3 · AMGN −0.3 · GILD −2.0
66 Jun 10, 2026−3.51%
Nothing on TECHgroup −2.8%, moved with TECH
66Jun 10, 2026−3.51%
Nothing on TECHNo TECH story, brief or results filing in our record that day
−2.8% moved with TECHMRNA −3.6 · GILD −3.2 · BIIB −2.4 · AMGN −2.0
67 Jun 11, 2026+2.90%
Nothing on TECHgroup +4.2%, moved with TECH
67Jun 11, 2026+2.90%
Nothing on TECHNo TECH story, brief or results filing in our record that day
+4.2% moved with TECHMRNA +7.9 · AMGN +4.8 · GILD +3.6 · BIIB +2.9
68 Jun 15, 2026+4.02%
Nothing on TECHgroup −0.9%, did not move with it
68Jun 15, 2026+4.02%
Nothing on TECHNo TECH story, brief or results filing in our record that day
−0.9% did not move with itMRNA +4.5 · BIIB −0.7 · GILD −1.0 · AMGN −1.3
69 Jun 18, 2026+5.35%
Nothing on TECHgroup −1.1%, did not move with it
69Jun 18, 2026+5.35%
Nothing on TECHNo TECH story, brief or results filing in our record that day
−1.1% did not move with itMRNA +3.5 · BIIB −1.1 · AMGN −1.2 · GILD −1.4
70 Jun 22, 2026−4.02%
Nothing on TECHgroup +1.3%, did not move with it
70Jun 22, 2026−4.02%
Nothing on TECHNo TECH story, brief or results filing in our record that day
+1.3% did not move with itMRNA −7.2 · GILD +0.9 · BIIB +1.6 · AMGN +2.1
71 Jun 24, 2026+4.65%
Nothing on TECHgroup +0.7%, did not move with it
71Jun 24, 2026+4.65%
Nothing on TECHNo TECH story, brief or results filing in our record that day
+0.7% did not move with itAMGN +1.3 · BIIB +1.2 · GILD +0.1 · MRNA −0.9
72 Jun 25, 2026+20.08%
Nothing on TECHgroup −0.3%, did not move with it
72Jun 25, 2026+20.08%
Nothing on TECHNo TECH story, brief or results filing in our record that day
−0.3% did not move with itBIIB +1.2 · AMGN +0.4 · GILD −1.1 · MRNA −1.1
A story on the same day is not a cause, and a group move is not proof either. Group: the median of AMGN, GILD, MRNA and BIIB that day, the largest companies in TECH’s SEC industry; “moved with TECH” means the same direction and at least half the size.
What’s next · results
Before the next report: what the first day after the last four did
Six trading days after each results filing (SEC 8-K, Item 2.02). TECH reports before the open, so day 1 is that day’s close. 2 of 4 times, day 6 ended on the same side as day 1.
Reported Nov 5, 2025
day 1−1.90%day 6+0.49%
Reported Feb 4, 2026
day 1+6.25%day 6−1.83%
Reported May 6, 2026
day 1−16.36%day 6−20.80%
Reported Aug 12, 2026
day 1+0.11%day 6+0.46%
Next report: expected early-to-mid NovemberEstimated from the dates of its last four results filings. Not announced. Since the Aug 12 report: +0.71%. Four reports is a small sample.
Each line is TECH’s close against its close before the filing, on licensed end-of-day closes. What happened after each report, not a forecast; a move on the day is not a cause.
Same industry
TECH against four biotech peers, a year at 100
TECH is up 26.6% in a year. Moderna is up 9.8 times, Biogen is up 56.9%, Amgen 43.8% and Gilead Sciences 41.0%. All four did more. Weekly closes, Nov 7, 2025 = 100, on a log scale so a 9.8-fold rise and a 26.6% rise both read honestly.
End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in TECH’s SEC industry (Biological Products, (No Diagnostic Substances)) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.